Sputum glucose as a marker of disease severity in adult patients with cystic fibrosis
Conclusion: Sputum glucose seems to act as a biomarker of disease severity which may complement patient clinical assessment and be a target for treatment.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Gramegna, A., Contarini, M., Aliberti, S., Sotgiu, G., Terranova, L., Oriano, M., Vanoni, N., Amati, F., Pizzamiglio, G., Di Pasquale, M., Dellafiore, S., Pappalettera, M., Assael, B. M., Blasi, F. Tags: Cystic fibrosis Source Type: research
More News: Cystic Fibrosis | Diabetes | Endocrinology | Italy Health | Microbiology | Respiratory Medicine | Study